These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38800261)

  • 21. Drug fever due to piperacillin/tazobactam loaded into bone cement.
    Park HB; Choi JS; Park SH; Kee WJ; Koh YI
    J Korean Med Sci; 2011 Feb; 26(2):301-3. PubMed ID: 21286026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.
    Kowalski ML; Woessner K; Sanak M
    J Allergy Clin Immunol; 2015 Aug; 136(2):245-51. PubMed ID: 26254051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia.
    Beaulieu C; Kurczewski L; Yajnik V
    J Thromb Thrombolysis; 2019 Jul; 48(1):167-170. PubMed ID: 30968302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis.
    LeClaire AC; Martin CA; Hoven AD
    Ann Pharmacother; 2004 Jun; 38(6):996-8. PubMed ID: 15113982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia.
    He X; Huang W; Wan X; Li X; Chang Q; Ding L
    J Int Med Res; 2023 Mar; 51(3):3000605231162434. PubMed ID: 36967671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Süleyman A; Tamay Z; Güler N
    Pediatr Pulmonol; 2022 Nov; 57(11):2622-2628. PubMed ID: 35833362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis.
    Kyriakou A; Zagalioti SC; Patsatsi A; Galanis N; Lazaridou E
    Case Rep Dermatol Med; 2019; 2019():3273987. PubMed ID: 31179136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center.
    Siami FS; LaFleur BJ; Siami GA
    Clin Ther; 2002 Jan; 24(1):59-72. PubMed ID: 11833836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug fever induced by piperacillin/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection.
    Swe T; Ali M; Naing AT
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27440850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
    Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
    Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
    Perry CM; Markham A
    Drugs; 1999 May; 57(5):805-43. PubMed ID: 10353303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipenem-resistant Pseudomonas aeruginosa treated with piperacillin/tazobactam in a patient with severe pneumonia: a case report and related literature review.
    He L; He A; Qian Y
    Ann Palliat Med; 2021 Jan; 10(1):810-817. PubMed ID: 33545803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    Boyce K; Brar H; Stabler SN
    J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R
    Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
    Kaye KS; Belley A; Barth P; Lahlou O; Knechtle P; Motta P; Velicitat P
    JAMA; 2022 Oct; 328(13):1304-1314. PubMed ID: 36194218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
    Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
    Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.
    D'Agostino C; Rhodes NJ; Skoglund E; Roberts JA; Scheetz MH
    J Infect Chemother; 2015 Oct; 21(10):742-6. PubMed ID: 26143049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
    Qian ET; Casey JD; Wright A; Wang L; Shotwell MS; Siemann JK; Dear ML; Stollings JL; Lloyd BD; Marvi TK; Seitz KP; Nelson GE; Wright PW; Siew ED; Dennis BM; Wrenn JO; Andereck JW; Han JH; Self WH; Semler MW; Rice TW;
    JAMA; 2023 Oct; 330(16):1557-1567. PubMed ID: 37837651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
    Kuye O; Teal J; DeVries VG; Morrow CA; Tally FP
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():113-24. PubMed ID: 8383652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.